Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Molecular Targeted Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT02139020
What this trial is testing

Collection of Plasma Samples for Squamous Cell Carcinoma of the Head and Neck Patients

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 400
Not applicableUnknownNCT03724097
What this trial is testing

Identification of Molecular Biomarkers for Cancer Target Therapy Efficacy

Who this might be right for
Cancer
OmicsWay Corp. 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT03155620
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Non-Hodgkin LymphomaAnn Arbor Stage IV Non-Hodgkin Lymphoma+42 more
National Cancer Institute (NCI) 1,377
Testing effectiveness (Phase 2)Active Not RecruitingNCT04699188
What this trial is testing

Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation

Who this might be right for
KRAS G12C Mutant Solid TumorsCarcinoma, Non-Small-Cell LungCarcinoma, Colorectal+7 more
Novartis Pharmaceuticals 344
Testing effectiveness (Phase 2)Study completedNCT04045613
What this trial is testing

Derazantinib and Atezolizumab in Patients With Urothelial Cancer

Who this might be right for
Urothelial Carcinoma
Basilea Pharmaceutica 95
Not applicableActive Not RecruitingNCT03835520
What this trial is testing

Prospective Collection of Tumor Biopsy and Plasma Samples From Cancer Patients Treated With Molecular Targeted Therapies or Immunotherapy

Who this might be right for
Cancer
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 200
Not applicableLooking for participantsNCT06876753
What this trial is testing

Regional Lymph Node Metastasis and Survival Outcomes in Advanced HCC

Who this might be right for
Hepatocellular Carcinoma (HCC)
Zhongda Hospital 300
Testing effectiveness (Phase 2)Ended earlyNCT02560012
What this trial is testing

Personalized Targeted Inhibitors Treatment in Renal Cell Cancer

Who this might be right for
Carcinoma, Renal Cell
The University of Texas Health Science Center, Houston 4
Not applicableStudy completedNCT02639871
What this trial is testing

Dynamic Neuroimaging Biomarkers in Huntington's Disease

Who this might be right for
Brain Neuroimaging Biomarkers in Huntington Disease
Assistance Publique - Hôpitaux de Paris 81
Not applicableUnknownNCT01566019
What this trial is testing

Molecular Screening for Cancer Treatment Optimization

Who this might be right for
Metastatic Solid Tumors (Any Localization)
Gustave Roussy, Cancer Campus, Grand Paris 2,150
Not applicableUnknownNCT05058937
What this trial is testing

Examine the Clinical Value of Comprehensive Genomic Profiling Performed by Belgian NGS Laboratories: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Centre

Who this might be right for
Solid TumorMetastatic Cancer
The Belgian Society of Medical Oncology 936
Testing effectiveness (Phase 2)UnknownNCT04185831
What this trial is testing

A MolEcularly Guided Anti-Cancer Drug Off-Label Trial

Who this might be right for
Solid Tumor
Uppsala University Hospital 167
Not applicableLooking for participantsNCT07658833
What this trial is testing

TACE and/or HAIC Combined With Molecular-targeted Therapy and Immunotherapy for HCC

Who this might be right for
Hepatocellular Carcinoma (HCC)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 120
Not applicableStudy completedNCT07302932
What this trial is testing

Metformin and Molecular Aging in Prediabetes

Who this might be right for
Metformin, Prediabetes
Diabetes Foundation, India 112
Not applicableUnknownNCT05750511
What this trial is testing

Multicenter Tissue Registry in Melanoma

Who this might be right for
Metastatic Melanoma
Dermatologic Cooperative Oncology Group 1,000
Large-scale testing (Phase 3)Looking for participantsNCT05770037
What this trial is testing

DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers

Who this might be right for
Haematological MalignancyMalignant NeoplasmLymphoproliferative Disorders+8 more
Cancer Research UK 30
Not applicableLooking for participantsNCT05027828
What this trial is testing

CtDNA as a Novel Biomarker of Treatment Efficacy in Patients With Ovarian Cancer

Who this might be right for
High-grade Serous Ovarian CancerCirculating Tumor DNA
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 100
Not applicableLooking for participantsNCT06924463
What this trial is testing

Identification of Specific Molecular Signatures in Pediatric, Adolescent, and Young Adult Rhabdomyosarcoma Through Spatial Proteome Analysis Using Mass Spectrometry

Who this might be right for
Rhabdomyosarcoma
Lille University 20
Testing effectiveness (Phase 2)Study completedNCT04720131
What this trial is testing

Camrelizumab Combined With Apatinib and Capecitabine in Patients With Advanced Biliary Tract Cancer.

Who this might be right for
Biliary Tract CancerAnti-PD-1 TherapyTargeted Molecular Therapy+1 more
Beijing Friendship Hospital 28
Testing effectiveness (Phase 2)Study completedNCT01467986
What this trial is testing

Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk Neuroblastoma

Who this might be right for
Neuroblastoma Recurrent
University of Regensburg 130
Next Page